指南与共识消化道肿瘤放疗

NRG肿瘤学国际共识勾画图谱:胰腺癌剂量递增放疗的靶区与剂量策略

NRG Oncology International Consensus Contouring Atlas on Target Volumes and Dosing Strategies for Dose-Escalated Pancreatic Cancer Radiation Therapy.
指南 / 共识 · Int J Radiat Oncol Biol Phys · 2024-11-06

国际专家小组(15名放射肿瘤科医生、2名外科医生和1名放射科医生)使用MimCloud软件对3例胰腺癌病例(交界可切除头部肿瘤、局部晚期头部肿瘤、医学上不可手术的尾部肿瘤)勾画高危和低危临床靶区(CTV)。基于同时真实性和性能水平估计(STAPLE)体积及Dice相似系数分析,作者达成共识体积:高危CTV包括肿瘤及毗邻血管,低危CTV根据肿瘤位置从腹腔干起始处或其上方1 cm延伸至第一空肠起始处的肠系膜上动脉水平。

要点

  • 共识高危CTV包括肿瘤及毗邻血管。
  • 头、颈和近端体部肿瘤的低危CTV从腹腔干起始处上方1 cm开始。
  • 远端体部和尾部肿瘤的低危CTV从腹腔干起始处开始,包括全尾及脾血管。

核心结论

  • 通过多学科协作制定了胰腺癌剂量递增放疗的共识勾画指南,这些体积包括大体肿瘤和常规选择性覆盖,可用于标准化未来试验的实践。

研究设计与样本

  • 国际专家小组共识,由15名放射肿瘤科医生、2名外科医生和1名放射科医生组成,使用MimCloud软件对3例胰腺癌病例勾画高危和低危CTV。

主要发现

  • 交界可切除头部、局部晚期头部和不可切除尾部肿瘤病例勾画的大体肿瘤体积分别为156.7、58.2和9.0 cc。
  • 高危和低危CTV的Dice相似系数(标准差)范围为0.45至0.82。

关键数值与推荐

  • 高危CTV包括肿瘤及毗邻血管。
  • 低危CTV在尾部和远端体部肿瘤从腹腔干起始处开始,在头、颈和近端体部肿瘤从腹腔干起始处上方1 cm开始,向下延伸至第一空肠起始处的肠系膜上动脉水平。
  • 对于头、颈和近端体部肿瘤,侧方体积包括整个胰头及腹腔干、肠系膜上动脉、肠系膜上静脉周围5至10 mm,包括肝总动脉和内侧门静脉,符合「Triangle」体积方法。
  • 对于远端体部和尾部肿瘤,包括整个尾以及脾血管和腹腔干起始处。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Dose-escalated radiation therapy is increasingly used in the treatment of pancreatic cancer; however, approaches to target delineation vary widely. We present the first North American cooperative group consensus contouring atlas for dose-escalated pancreatic cancer radiation therapy. METHODS AND MATERIALS: An expert international panel comprising 15 radiation oncologists, 2 surgeons, and 1 radiologist was recruited. Participants used MimCloud software to contour high- and low-risk clinical target volumes (CTVs) on 3 pancreatic cancer cases: a borderline resectable head tumor, a locally advanced head tumor, and a medically inoperable tail tumor. Simultaneous Truth and Performance Level Estimation volumes were created, and contours were analyzed using Dice similarity coefficients. RESULTS: The contoured gross tumor volume for the borderline head, locally advanced head, and unresectable tail tumor cases were 156.7, 58.2, and 9.0 cc, respectively, and the Dice similarity coefficients (SD) for the high- and low-risk CTV ranged from 0.45 to 0.82. Consensus volumes were agreed upon by authors. High-risk CTVs comprised the tumor plus abutting vessels. Low-risk CTVs started superiorly at (tail and distal body tumors) or 1 cm above (head, neck and proximal body tumors) the celiac takeoff and extended inferiorly to the superior mesenteric artery at the level of the first jejunal takeoff. For head, neck, and proximal body tumors, the lateral volume encompassed the entire pancreas head and 5 to 10 mm around the celiac, superior mesenteric artery, superior mesenteric vein, including the common hepatic artery and medial portal vein, consistent with a "Triangle" volume-based approach. For distal body and tail tumors, the entire tail was included, along with the splenic vessels and the takeoffs of celiac artery. CONCLUSIONS: Through multidisciplinary collaboration, we created consensus contouring guidelines for dose-escalated pancreatic cancer radiation therapy. These volumes include not only gross disease, but also routine elective coverage, and can be used to standardize practice for future trials seeking to define the role of dose-escalated radiation therapy in pancreatic cancer.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Sanford NN, Narang AK, Aguilera TA, et al. NRG Oncology International Consensus Contouring Atlas on Target Volumes and Dosing Strategies for Dose-Escalated Pancreatic Cancer Radiation Therapy. Int J Radiat Oncol Biol Phys. 2024. PMID: 39510320. doi:10.1016/j.ijrobp.2024.10.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。